These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28232469)

  • 1. A myeloid tumor suppressor role for
    Stanley RF; Piszczatowski RT; Bartholdy B; Mitchell K; McKimpson WM; Narayanagari S; Walter D; Todorova TI; Hirsch C; Makishima H; Will B; McMahon C; Gritsman K; Maciejewski JP; Kitsis RN; Steidl U
    J Exp Med; 2017 Mar; 214(3):753-771. PubMed ID: 28232469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow-specific loss of
    Chorzalska A; Morgan J; Ahsan N; Treaba DO; Olszewski AJ; Petersen M; Kingston N; Cheng Y; Lombardo K; Schorl C; Yu X; Zini R; Pacilli A; Tepper A; Coburn J; Hryniewicz-Jankowska A; Zhao TC; Oancea E; Reagan JL; Liang O; Kotula L; Quesenberry PJ; Gruppuso PA; Manfredini R; Vannucchi AM; Dubielecka PM
    Blood; 2018 Nov; 132(19):2053-2066. PubMed ID: 30213875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.
    Pikman Y; Lee BH; Mercher T; McDowell E; Ebert BL; Gozo M; Cuker A; Wernig G; Moore S; Galinsky I; DeAngelo DJ; Clark JJ; Lee SJ; Golub TR; Wadleigh M; Gilliland DG; Levine RL
    PLoS Med; 2006 Jul; 3(7):e270. PubMed ID: 16834459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JAK-STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response.
    Kleppe M; Kwak M; Koppikar P; Riester M; Keller M; Bastian L; Hricik T; Bhagwat N; McKenney AS; Papalexi E; Abdel-Wahab O; Rampal R; Marubayashi S; Chen JJ; Romanet V; Fridman JS; Bromberg J; Teruya-Feldstein J; Murakami M; Radimerski T; Michor F; Fan R; Levine RL
    Cancer Discov; 2015 Mar; 5(3):316-31. PubMed ID: 25572172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tat-NOL3 protects against hippocampal neuronal cell death induced by oxidative stress through the regulation of apoptotic pathways.
    Sohn EJ; Shin MJ; Eum WS; Kim DW; Yong JI; Ryu EJ; Park JH; Cho SB; Cha HJ; Kim SJ; Yeo HJ; Yeo EJ; Choi YJ; Im SK; Kweon HY; Kim DS; Yu YH; Cho SW; Park M; Park J; Cho YJ; Choi SY
    Int J Mol Med; 2016 Jul; 38(1):225-35. PubMed ID: 27221790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecularly pathogenesis and molecular targeted therapy for myeloproliferative neoplasms].
    Shide K
    Rinsho Ketsueki; 2015 Feb; 56(2):150-8. PubMed ID: 25765794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Not Available].
    Mosca M; Vertenoeil G; Toppaldoddi KR; Plo I; Vainchenker W
    Bull Cancer; 2016 Jun; 103(6 Suppl 1):S16-28. PubMed ID: 27494969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p19(ARF) /p14(ARF) controls oncogenic functions of signal transducer and activator of transcription 3 in hepatocellular carcinoma.
    Schneller D; Machat G; Sousek A; Proell V; van Zijl F; Zulehner G; Huber H; Mair M; Muellner MK; Nijman SM; Eferl R; Moriggl R; Mikulits W
    Hepatology; 2011 Jul; 54(1):164-72. PubMed ID: 21452288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin.
    Wang X; Liu Q; Ihsan A; Huang L; Dai M; Hao H; Cheng G; Liu Z; Wang Y; Yuan Z
    Toxicol Sci; 2012 Jun; 127(2):412-24. PubMed ID: 22454431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of Stat3 enhances myeloid cell expansion and increases the severity of myeloproliferative neoplasms in Jak2V617F knock-in mice.
    Yan D; Jobe F; Hutchison RE; Mohi G
    Leukemia; 2015 Oct; 29(10):2050-61. PubMed ID: 26044284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science.
    Kilpivaara O; Levine RL
    Leukemia; 2008 Oct; 22(10):1813-7. PubMed ID: 18754026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloproliferative neoplasms: A decade of discoveries and treatment advances.
    Tefferi A
    Am J Hematol; 2016 Jan; 91(1):50-8. PubMed ID: 26492355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small RNA Sequencing Uncovers New miRNAs and moRNAs Differentially Expressed in Normal and Primary Myelofibrosis CD34+ Cells.
    Guglielmelli P; Bisognin A; Saccoman C; Mannarelli C; Coppe A; Vannucchi AM; Bortoluzzi S
    PLoS One; 2015; 10(10):e0140445. PubMed ID: 26468945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice.
    Zhang W; Sun HC; Wang WQ; Zhang QB; Zhuang PY; Xiong YQ; Zhu XD; Xu HX; Kong LQ; Wu WZ; Wang L; Song TQ; Li Q; Tang ZY
    Gastroenterology; 2012 Dec; 143(6):1641-1649.e5. PubMed ID: 22922424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukemia inhibitory factor regulates differentiation of trophoblastlike BeWo cells through the activation of JAK/STAT and MAPK3/1 MAP kinase-signaling pathways.
    Leduc K; Bourassa V; Asselin E; Leclerc P; Lafond J; Reyes-Moreno C
    Biol Reprod; 2012 Feb; 86(2):54. PubMed ID: 22053093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P-Selectin Sustains Extramedullary Hematopoiesis in the Gata1 low Model of Myelofibrosis.
    Spangrude GJ; Lewandowski D; Martelli F; Marra M; Zingariello M; Sancillo L; Rana RA; Migliaccio AR
    Stem Cells; 2016 Jan; 34(1):67-82. PubMed ID: 26439305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinase signaling and targeted therapy for primary myelofibrosis.
    Yang Q; Crispino JD; Wen QJ
    Exp Hematol; 2017 Apr; 48():32-38. PubMed ID: 28043820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary myelofibrosis: update on definition, pathogenesis, and treatment.
    Abdel-Wahab OI; Levine RL
    Annu Rev Med; 2009; 60():233-45. PubMed ID: 18947294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOCS3 Deficiency in Myeloid Cells Promotes Tumor Development: Involvement of STAT3 Activation and Myeloid-Derived Suppressor Cells.
    Yu H; Liu Y; McFarland BC; Deshane JS; Hurst DR; Ponnazhagan S; Benveniste EN; Qin H
    Cancer Immunol Res; 2015 Jul; 3(7):727-40. PubMed ID: 25649351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth arrest and DNA damage 45G down-regulation contributes to Janus kinase/signal transducer and activator of transcription 3 activation and cellular senescence evasion in hepatocellular carcinoma.
    Zhang L; Yang Z; Ma A; Qu Y; Xia S; Xu D; Ge C; Qiu B; Xia Q; Li J; Liu Y
    Hepatology; 2014 Jan; 59(1):178-89. PubMed ID: 23897841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.